Wheatley and Gopalsami Highlight the Value of Interdisciplinary Collaboration in HSCT Care
May 19th 2023Tia Wheatley, DNP, RN, AOCNS, BMTCN, and Shivani Gopalsami, RN, MSN, ANP-BC, AOCNP, discuss the benefits and challenges of multidisciplinary collaboration in hematopoietic stem cell transplant care.
Arash Rezazadeh Kalebasty Discusses Darolutamide Combination Safety in the ARASENS Study
March 31st 2023Arash Rezazadeh Kalebasty, MD, discusses the rates of dose reduction and treatment discontinuation for patients with hormone-sensitive prostate cancer receiving combination therapy with darolutamide.
Mehra Details the Importance of PD-L1 Expression in HNSCC Treatment Selection
November 25th 2022Ranee Mehra, MD, discusses the link between PD-L1 expression and increased immunotherapy efficacy in head and neck squamous cell carcinoma, and what future treatment options may look like for patients in this space.